Get informed when a big investor buys or sells
+ Follow-2.42
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for NMTC is -2.42. That is below the sector sector average of -0.06. Investors often review this figure alongside NeuroOne Medical Technologies's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, NMTC currently prints -2.42 for PEG ratio, while the sector average sits near -0.06. That is roughly 4033.6% below the sector mean. Large gaps often invite a closer look at NeuroOne Medical Technologies's growth, margins, and balance sheet.
A PEG ratio of -2.42 for NeuroOne Medical Technologies is not 'good' or 'bad' on its own. Compare it with the peer average (-0.06) and with NMTC's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting NMTC's PEG ratio (-2.42), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.